Mercy Assisted Care 901 Mineral Point Ave, Janesville, WI, 53548 | |
(608) 754-2201 |
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
Name | Mercy Assisted Care |
---|---|
Location | 901 Mineral Point Ave, Janesville, Wisconsin |
Hospice ID | 521550 |
Category | Part of a Home Health Agency |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 520 |
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
NPI Number | 1104971050 |
Organization Name | Mercy Assisted Care, Inc |
Address | 901 Mineral Point Ave Janesville, Wisconsin, 53548 |
Phone Number | (608)754-2201 |
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.3 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
Home Health Aides | 2 |
Counselors | 1 |
Medical Social Workers | 1 |
Registered Nurses | 7 |
Total Employees | 11 |
---|
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
Homemakers | 0.3 |
Total Volunteers | 0.3 |
---|
News Archive
Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.
The American Society of Anesthesiologists applauds efforts by Congressman Raul Ruiz, M.D. (D-CA) and Congressman Larry Bucshon, M.D. (R-IN) to amend surprise medical bill legislation as it passed the House Energy and Commerce Committee.
NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and Edge Therapeutics, Inc., a specialty biopharmaceutical company that transforms proven, off-patent drugs into targeted, locally delivered therapies for neurological disorders, announced today that the companies have entered into a licensing agreement for drug delivery technology.
The monoclonal antibody SR1 can significantly inhibit gastrointestinal stromal tumor cell growth, report researchers in the Proceedings of the National Academy of Sciences.
› Verified 1 days ago
Mercy Assisted Care Location: 901 Mineral Point Ave, Janesville, Wisconsin, 53548 Phone: (608) 754-2201 |